ID   BMP2K_HUMAN             Reviewed;        1161 AA.
AC   Q9NSY1; O94791; Q4W5H2; Q8IYF2; Q8N2G7; Q8NHG9; Q9NTG8;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   22-AUG-2003, sequence version 2.
DT   15-MAR-2017, entry version 154.
DE   RecName: Full=BMP-2-inducible protein kinase;
DE            Short=BIKe;
DE            EC=2.7.11.1;
GN   Name=BMP2K; Synonyms=BIKE; ORFNames=HRIHFB2017;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Synovium, and Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   SER-405.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 537-1161 (ISOFORM 2).
RC   TISSUE=Ovary;
RA   Guo J.H., Yu L.;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 946-1161 (ISOFORM 1), AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=9853615; DOI=10.1038/4315;
RA   Ueki N., Oda T., Kondo M., Yano K., Noguchi T., Muramatsu M.-A.;
RT   "Selection system for genes encoding nuclear-targeted proteins.";
RL   Nat. Biotechnol. 16:1338-1342(1998).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1107, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-834 AND SER-1076, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14 AND SER-1107, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1029 AND SER-1032, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1029; SER-1107 AND
RP   SER-1111, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-689; SER-742; SER-817;
RP   SER-818; SER-1029; SER-1032; SER-1041; SER-1107 AND SER-1111, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14 AND SER-1039, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-68; VAL-212 AND HIS-288.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May be involved in osteoblast differentiation.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9853615}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9NSY1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NSY1-2; Sequence=VSP_008091, VSP_008092;
CC       Name=3;
CC         IsoId=Q9NSY1-3; Sequence=VSP_008093, VSP_008091, VSP_008092;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Autophosphorylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK075278; BAC11515.1; -; mRNA.
DR   EMBL; AK292147; BAF84836.1; -; mRNA.
DR   EMBL; AL137275; CAB70673.1; -; mRNA.
DR   EMBL; AL137661; CAB70863.1; -; mRNA.
DR   EMBL; AC098818; AAY40926.1; -; Genomic_DNA.
DR   EMBL; BC036021; AAH36021.1; -; mRNA.
DR   EMBL; AF527532; AAM88867.1; -; mRNA.
DR   EMBL; AB015331; BAA34790.1; -; mRNA.
DR   CCDS; CCDS34019.1; -. [Q9NSY1-2]
DR   CCDS; CCDS47083.1; -. [Q9NSY1-1]
DR   PIR; T46347; T46347.
DR   PIR; T46364; T46364.
DR   RefSeq; NP_060063.2; NM_017593.3. [Q9NSY1-2]
DR   RefSeq; NP_942595.1; NM_198892.1. [Q9NSY1-1]
DR   UniGene; Hs.146551; -.
DR   PDB; 4W9W; X-ray; 1.72 A; A=39-344.
DR   PDB; 4W9X; X-ray; 2.14 A; A=38-345.
DR   PDB; 5I3O; X-ray; 2.40 A; A/B=42-343.
DR   PDB; 5I3R; X-ray; 2.40 A; A/B=42-343.
DR   PDB; 5IKW; X-ray; 2.41 A; A=38-345.
DR   PDBsum; 4W9W; -.
DR   PDBsum; 4W9X; -.
DR   PDBsum; 5I3O; -.
DR   PDBsum; 5I3R; -.
DR   PDBsum; 5IKW; -.
DR   ProteinModelPortal; Q9NSY1; -.
DR   SMR; Q9NSY1; -.
DR   BioGrid; 120735; 50.
DR   IntAct; Q9NSY1; 38.
DR   STRING; 9606.ENSP00000334836; -.
DR   BindingDB; Q9NSY1; -.
DR   ChEMBL; CHEMBL4522; -.
DR   GuidetoPHARMACOLOGY; 1941; -.
DR   iPTMnet; Q9NSY1; -.
DR   PhosphoSitePlus; Q9NSY1; -.
DR   BioMuta; BMP2K; -.
DR   DMDM; 34222653; -.
DR   EPD; Q9NSY1; -.
DR   MaxQB; Q9NSY1; -.
DR   PaxDb; Q9NSY1; -.
DR   PeptideAtlas; Q9NSY1; -.
DR   PRIDE; Q9NSY1; -.
DR   DNASU; 55589; -.
DR   Ensembl; ENST00000335016; ENSP00000334836; ENSG00000138756. [Q9NSY1-1]
DR   Ensembl; ENST00000502871; ENSP00000421768; ENSG00000138756. [Q9NSY1-2]
DR   GeneID; 55589; -.
DR   KEGG; hsa:55589; -.
DR   UCSC; uc003hlj.4; human. [Q9NSY1-1]
DR   CTD; 55589; -.
DR   DisGeNET; 55589; -.
DR   GeneCards; BMP2K; -.
DR   HGNC; HGNC:18041; BMP2K.
DR   HPA; HPA026436; -.
DR   HPA; HPA026451; -.
DR   HPA; HPA026501; -.
DR   neXtProt; NX_Q9NSY1; -.
DR   OpenTargets; ENSG00000138756; -.
DR   PharmGKB; PA134992822; -.
DR   eggNOG; KOG1989; Eukaryota.
DR   eggNOG; ENOG410Y515; LUCA.
DR   GeneTree; ENSGT00870000136426; -.
DR   HOGENOM; HOG000232173; -.
DR   HOVERGEN; HBG050703; -.
DR   InParanoid; Q9NSY1; -.
DR   KO; K08854; -.
DR   OMA; VPFISHP; -.
DR   OrthoDB; EOG091G02KI; -.
DR   PhylomeDB; Q9NSY1; -.
DR   TreeFam; TF335936; -.
DR   SignaLink; Q9NSY1; -.
DR   ChiTaRS; BMP2K; human.
DR   GeneWiki; BMP2K; -.
DR   GenomeRNAi; 55589; -.
DR   PRO; PR:Q9NSY1; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000138756; -.
DR   CleanEx; HS_BMP2K; -.
DR   ExpressionAtlas; Q9NSY1; baseline and differential.
DR   Genevisible; Q9NSY1; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0035612; F:AP-2 adaptor complex binding; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019208; F:phosphatase regulator activity; IBA:GO_Central.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0030500; P:regulation of bone mineralization; IBA:GO_Central.
DR   GO; GO:2000369; P:regulation of clathrin-dependent endocytosis; IBA:GO_Central.
DR   InterPro; IPR026105; BMP-2-ind_kinase.
DR   InterPro; IPR028182; BMP2K_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR22967:SF79; PTHR22967:SF79; 1.
DR   Pfam; PF15282; BMP2K_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1   1161       BMP-2-inducible protein kinase.
FT                                /FTId=PRO_0000085663.
FT   DOMAIN       51    316       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      57     65       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS     12     40       Gly-rich.
FT   COMPBIAS    425    559       Gln/His-rich.
FT   ACT_SITE    180    180       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      79     79       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     689    689       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     742    742       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     817    817       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     818    818       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     834    834       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     928    928       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91Z96}.
FT   MOD_RES    1029   1029       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1031   1031       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91Z96}.
FT   MOD_RES    1032   1032       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1039   1039       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1041   1041       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1076   1076       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES    1107   1107       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1111   1111       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     330    340       NSSIPSALPEP -> KCCKQLLRHGALLTEILLFLQLFLNR
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_008093.
FT   VAR_SEQ     651    662       NRLEERASSDKN -> SKGHLKAYFASQ (in isoform
FT                                2 and isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_008091.
FT   VAR_SEQ     663   1161       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_008092.
FT   VARIANT      68     68       V -> M (in a lung squamous cell carcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs770167074).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040388.
FT   VARIANT     212    212       D -> V (in dbSNP:rs56143363).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040389.
FT   VARIANT     288    288       R -> H (in dbSNP:rs55782848).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040390.
FT   VARIANT     405    405       G -> S (in dbSNP:rs2288255).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_051618.
FT   VARIANT     486    486       Q -> H (in dbSNP:rs2114202).
FT                                /FTId=VAR_059765.
FT   VARIANT    1002   1002       T -> S (in dbSNP:rs12507099).
FT                                /FTId=VAR_051619.
FT   CONFLICT    342    342       T -> A (in Ref. 4; AAH36021).
FT                                {ECO:0000305}.
FT   CONFLICT    471    486       Missing (in Ref. 2; CAB70863).
FT                                {ECO:0000305}.
FT   CONFLICT    478    478       Q -> R (in Ref. 4; AAH36021).
FT                                {ECO:0000305}.
FT   STRAND       43     46       {ECO:0000244|PDB:4W9W}.
FT   STRAND       49     59       {ECO:0000244|PDB:4W9W}.
FT   STRAND       64     70       {ECO:0000244|PDB:4W9W}.
FT   STRAND       75     85       {ECO:0000244|PDB:4W9W}.
FT   HELIX        86    102       {ECO:0000244|PDB:4W9W}.
FT   STRAND      111    118       {ECO:0000244|PDB:4W9W}.
FT   STRAND      120    122       {ECO:0000244|PDB:4W9W}.
FT   STRAND      124    131       {ECO:0000244|PDB:4W9W}.
FT   HELIX       138    144       {ECO:0000244|PDB:4W9W}.
FT   TURN        145    148       {ECO:0000244|PDB:4W9W}.
FT   HELIX       152    170       {ECO:0000244|PDB:4W9W}.
FT   STRAND      172    174       {ECO:0000244|PDB:4W9W}.
FT   HELIX       183    185       {ECO:0000244|PDB:4W9W}.
FT   STRAND      186    188       {ECO:0000244|PDB:4W9W}.
FT   STRAND      194    196       {ECO:0000244|PDB:4W9W}.
FT   HELIX       199    201       {ECO:0000244|PDB:4W9W}.
FT   HELIX       209    212       {ECO:0000244|PDB:4W9W}.
FT   HELIX       214    224       {ECO:0000244|PDB:4W9W}.
FT   HELIX       227    229       {ECO:0000244|PDB:4W9W}.
FT   HELIX       232    234       {ECO:0000244|PDB:4W9W}.
FT   HELIX       245    261       {ECO:0000244|PDB:4W9W}.
FT   TURN        265    268       {ECO:0000244|PDB:4W9W}.
FT   HELIX       270    275       {ECO:0000244|PDB:4W9W}.
FT   HELIX       288    297       {ECO:0000244|PDB:4W9W}.
FT   HELIX       302    304       {ECO:0000244|PDB:4W9W}.
FT   HELIX       308    318       {ECO:0000244|PDB:4W9W}.
SQ   SEQUENCE   1161 AA;  129172 MW;  5C38A86E95935EC2 CRC64;
     MKKFSRMPKS EGGSGGGAAG GGAGGAGAGA GCGSGGSSVG VRVFAVGRHQ VTLEESLAEG
     GFSTVFLVRT HGGIRCALKR MYVNNMPDLN VCKREITIMK ELSGHKNIVG YLDCAVNSIS
     DNVWEVLILM EYCRAGQVVN QMNKKLQTGF TEPEVLQIFC DTCEAVARLH QCKTPIIHRD
     LKVENILLND GGNYVLCDFG SATNKFLNPQ KDGVNVVEEE IKKYTTLSYR APEMINLYGG
     KPITTKADIW ALGCLLYKLC FFTLPFGESQ VAICDGNFTI PDNSRYSRNI HCLIRFMLEP
     DPEHRPDIFQ VSYFAFKFAK KDCPVSNINN SSIPSALPEP MTASEAAARK SQIKARITDT
     IGPTETSIAP RQRPKANSAT TATPSVLTIQ SSATPVKVLA PGEFGNHRPK GALRPGNGPE
     ILLGQGPPQQ PPQQHRVLQQ LQQGDWRLQQ LHLQHRHPHQ QQQQQQQQQQ QQQQQQQQQQ
     QQQQQQHHHH HHHHLLQDAY MQQYQHATQQ QQMLQQQFLM HSVYQPQPSA SQYPTMMPQY
     QQAFFQQQML AQHQPSQQQA SPEYLTSPQE FSPALVSYTS SLPAQVGTIM DSSYSANRSV
     ADKEAIANFT NQKNISNPPD MSGWNPFGED NFSKLTEEEL LDREFDLLRS NRLEERASSD
     KNVDSLSAPH NHPPEDPFGS VPFISHSGSP EKKAEHSSIN QENGTANPIK NGKTSPASKD
     QRTGKKTSVQ GQVQKGNDES ESDFESDPPS PKSSEEEEQD DEEVLQGEQG DFNDDDTEPE
     NLGHRPLLMD SEDEEEEEKH SSDSDYEQAK AKYSDMSSVY RDRSGSGPTQ DLNTILLTSA
     QLSSDVAVET PKQEFDVFGA VPFFAVRAQQ PQQEKNEKNL PQHRFPAAGL EQEEFDVFTK
     APFSKKVNVQ ECHAVGPEAH TIPGYPKSVD VFGSTPFQPF LTSTSKSESN EDLFGLVPFD
     EITGSQQQKV KQRSLQKLSS RQRRTKQDMS KSNGKRHHGT PTSTKKTLKP TYRTPERARR
     HKKVGRRDSQ SSNEFLTISD SKENISVALT DGKDRGNVLQ PEESLLDPFG AKPFHSPDLS
     WHPPHQGLSD IRADHNTVLP GRPRQNSLHG SFHSADVLKM DDFGAVPFTE LVVQSITPHQ
     SQQSQPVELD PFGAAPFPSK Q
//
